Lauren Santye, Assistant Editor

Risk of AMD reduced by more than one-third in individuals who closely follow a Mediterranean diet rich in fruit.

Keytruda approved as a first-line treatment for non-small cell lung cancer.

Swedish study suggests that more American men can opt surveillance over prostate cancer treatment.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best support patients on a specialty drug therapy.

Although any amount of exercise is beneficial, exceeding the recommended level produces the most benefits for diabetes patients.

Ibalizumab for multi-drug resistant HIV showed significant promise fighting the disease.

Top news of the day from across the health care landscape.

Ibalizumab achieves primary endpoint in decreasing the viral load of patients with drug-resistant HIV.

New findings reveal 2 subsets of the disease which may have an effect on how the disease responds to standard therapy.

A specific mark in histones speeds up repairs in cancer cells, increasing their resistance to treatment.

Top news of the day from across the health care landscape.

A novel approach looks to provide researchers with the tools to make accurate and safe predictions for cancer patients.

Study reveals that more than 50% of Americans are suffering from at least 1 chronic medical condition, mental illness, or substance abuse/dependence.

An automated algorithm was able to select HIV-positive individuals who would benefit the most from PrEP.

As symptoms of depression worsen, so too does the length of survival in lung cancer patients, according to a study published in the Journal of Clinical Oncology.

Unexpected benefits seen in patients with hemophilia A when a common protein was blocked.

Fission yeast is a low cost and fast system that can improve the cancer drug discovery process.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, director of Pharmacy Services for Independent Health, discusses developments in the specialty pharmacy landscape for stakeholders to monitor.

A drug used to treat kidney cancer could be effective fighting several types of the disease.

Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.

Parts of a protein used in some HCV vaccine candidates are far too flexible to be successful.

Researchers seek to improve HIV drug therapies through nanomedicine.

A nonsteroid anti-inflammatory drug used to treat common colds blocks bladder cancer cells from spreading in mice.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The widely publicized untested oncology drug scandal could lead to better clinical practice.

Pharmacists should keep tabs on the mental state of patients treated for lung cancer.

First-line pembrolizumab in addition to standard chemotherapy improved response rates and survival in patients with advanced non-small cell lung cancer.